Lee MM - Search Results

1

Müllerian inhibiting substance as a marker for ovarian sex-cord tumor.

Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, Fuller AF Jr. Gustafson ML, et al. Among authors: lee mm. N Engl J Med. 1992 Feb 13;326(7):466-71. doi: 10.1056/NEJM199202133260707. N Engl J Med. 1992. PMID: 1732773 Free article. No abstract available.

2

Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.

Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Misra M, et al. Among authors: lee mm. J Clin Endocrinol Metab. 2002 Aug;87(8):3598-602. doi: 10.1210/jcem.87.8.8742. J Clin Endocrinol Metab. 2002. PMID: 12161481

3

The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.

Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Misra M, et al. Among authors: lee mm. J Clin Endocrinol Metab. 2003 Feb;88(2):787-92. doi: 10.1210/jc.2002-020889. J Clin Endocrinol Metab. 2003. PMID: 12574214

4

Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.

Lee MM, Cate RL, Donahoe PK, Waneck GL. Lee MM, et al. Endocrinology. 1992 Feb;130(2):847-53. doi: 10.1210/endo.130.2.1346380. Endocrinology. 1992. PMID: 1346380

5

Developmental changes in mullerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis.

Lee MM, Gustafson ML, Ukiyama E, Donahoe PK, MacLaughlin DT, Wexler M, Keeping HS. Lee MM, et al. J Clin Endocrinol Metab. 1994 Mar;78(3):615-21. doi: 10.1210/jcem.78.3.8126132. J Clin Endocrinol Metab. 1994. PMID: 8126132

6

Mullerian inhibiting substance: a gonadal hormone with multiple functions.

Lee MM, Donahoe PK. Lee MM, et al. Endocr Rev. 1993 Apr;14(2):152-64. doi: 10.1210/edrv-14-2-152. Endocr Rev. 1993. PMID: 8325249 Review.

7

Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities.

Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, Donahoe PK. Gustafson ML, et al. Among authors: lee mm. J Pediatr Surg. 1993 Mar;28(3):439-44. doi: 10.1016/0022-3468(93)90245-g. J Pediatr Surg. 1993. PMID: 8468660

8

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Lee MM, et al. J Clin Endocrinol Metab. 1996 Feb;81(2):571-6. doi: 10.1210/jcem.81.2.8636269. J Clin Endocrinol Metab. 1996. PMID: 8636269

9

Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.

Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT. Lee MM, et al. N Engl J Med. 1997 May 22;336(21):1480-6. doi: 10.1056/NEJM199705223362102. N Engl J Med. 1997. PMID: 9154766 Free article.

10

Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors.

Lane AH, Lee MM, Fuller AF Jr, Kehas DJ, Donahoe PK, MacLaughlin DT. Lane AH, et al. Among authors: lee mm. Gynecol Oncol. 1999 Apr;73(1):51-5. doi: 10.1006/gyno.1998.5290. Gynecol Oncol. 1999. PMID: 10094880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

910 results

Search Page

Filters